Clinical Trial Update: Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Pandel Cream 0.1% on the HPA axis in pediatric and adult patients with psoriasis or atopic dermatitis; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• Pandel Cream 0.1%

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Psoriasis, Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2016-03-29